Oxytocin nasal spray for ADHD and autism: what the research actually says

What did @injectorcat1 actually say?

The creator, a self-described nurse with AuDHD (co-occurring autism and ADHD), says oxytocin nasal spray has helped regulate her nervous system after two months of use. She also claims that taking omeprazole (Prilosec) for histamine helped her PMDD-related depression, sometimes within "10 to 20 to 30 minutes." She frames all of this as personal experimentation, not medical advice, but she does tell viewers to "just pop a Prilosec" if they feel like they want to kill themselves. That framing is a problem we will get to.

For the oxytocin piece specifically, she says she researched intranasal oxytocin "for people that have autism" and that it has helped her manage social masking and nervous system dysregulation. She does not name a dose, a brand, or a protocol, which is worth noting.

Does the science back this up?

The honest answer is: partially, and with serious caveats. Intranasal oxytocin has been studied in autism, but the results are far messier than TikTok makes them sound. The nervous system dysregulation angle has some theoretical backing, but clinical proof is thin.

The most rigorous trial to date, Sikich et al. (2021, NEJM), was a large randomized controlled trial of intranasal oxytocin in autistic children and found no significant improvement in social functioning compared to placebo. That is not a small study you can wave away. Earlier smaller trials, like Guastella et al. (2010, Biological Psychiatry), showed some improvements in emotion recognition, but these were short-term, used narrow outcome measures, and have not reliably replicated at scale.

On the ADHD and nervous system dysregulation side, the evidence is even thinner. There are animal models and theoretical frameworks suggesting oxytocin modulates the HPA axis and stress response, but human RCT data in ADHD specifically is nearly nonexistent as of 2024.

The histamine-PMDD-depression connection she describes has more legitimate footing in emerging research than most people realize, which we will cover next.

What did they get wrong (or right)?

She got the histamine-PMDD link more right than wrong. Research by Maintz and Novak (2007, American Journal of Clinical Nutrition) and more recent work on mast cell activation in premenstrual disorders suggests histamine metabolism is genuinely disrupted by fluctuating estrogen. Estrogen stimulates histamine release and also inhibits diamine oxidase, the enzyme that breaks histamine down. So the theoretical basis for why an H2 blocker like omeprazole might blunt some PMDD symptoms is not crazy.

What she got wrong: omeprazole is a proton pump inhibitor, not an antihistamine. She conflates it with famotidine (Pepcid), which is an H2 blocker and acts on histamine receptors directly. These are different mechanisms. She acknowledges the difference briefly but then recommends omeprazole for its antihistamine-like effect, which is not accurate pharmacology.

The claim that oxytocin spray helped her social masking is unverifiable based on self-report alone. The Sikich 2021 NEJM data should make anyone cautious about confident claims here.

Most seriously, she tells viewers who feel suicidal to take an OTC antacid and "see how you feel." That is not a safe or appropriate recommendation, regardless of intent.

What should you actually know?

Intranasal oxytocin is not FDA-approved for autism, ADHD, or mood regulation. It exists in a gray zone: compounded formulations are available through some telehealth and peptide clinics, but the regulatory status is unsettled and quality control across suppliers varies significantly.

If you are genuinely interested in the oxytocin research for autism or nervous system support, the honest picture is that we do not yet have consistent human trial data showing it works for the outcomes this creator describes. The Sikich et al. NEJM trial is the largest and most rigorous, and it was negative.

The histamine-mental health connection is a legitimately interesting area of research, particularly for people with MCAS, PMDD, or suspected histamine intolerance. But self-treating suicidal ideation with an OTC acid reducer is not a substitute for crisis support or professional evaluation.

• If you are experiencing suicidal thoughts, contact the 988 Suicide and Crisis Lifeline by calling or texting 988.
• Oxytocin nasal spray should only be used under clinical supervision, with appropriate screening for contraindications.
• Do not substitute H2 blockers or PPIs for mental health treatment without discussing it with a provider who knows your full history.

The creator clearly has real experience navigating a complex set of overlapping conditions. That lived experience matters. But personal anecdote plus nursing credentials does not equal clinical evidence, and the audience following this content deserves that distinction drawn clearly.